Sunday, February 14, 2016

Four former Synthes executives excluded from federal health-care programs

Four former Synthes executives are out of prison but on Tuesday were officially excluded from federal health-care programs, meaning any company employing them won't be reimbursed for drugs or services.

Four former Synthes executives excluded from federal health-care programs


Four former executives of medical device manufacturer Synthes, Inc., who went to federal prison for their role in an illegal clinical trial of bone cement, are out of prison now but probably won't be working in health care anytime soon.

Michael Huggins, Thomas Higgins, Richard Bohner and John Walsh were officially excluded from federal health-care programs on Tuesday, meaning no company employing them will be eligible to receive reimbursement for services or drugs through programs such as Medicare and Medicaid. Given the private sector's dependence on government money, companies rarely hire people on the excluded list.

The Office of Inspector General of the Department of Health & Human Services has been implementing exclusions since about 1981. HHS began imposing the penalties in 1977. A link to the OIG site is here.

Many exclusions last for five years. After the exclusion period, reinstatement is not automatic and must be applied for.

The prison sentences set new marks for health-care fraud cases prosecuted under the responsible corporate officer doctrine.

All four men lived in suburban Philadelphia while working for Synthes, which was based in Switzerland and had its U.S. headquarters in West Chester. The company was among the industry leaders in making rods and plates, screws and nails to fix broken bones.

In the early 2000s, while trying to tap into the lucrative market for a particular type of spinal surgery, Synthes taught surgeons how to use its Norian bone cement without FDA approval for that procedure and conducted unauthorized trials on humans. Three patients died on the operating table in 2003-04.

Synthes and its subsidiary, Norian, pleaded guilty to federal charges and paid fines of $23 million.

Hansjorg Wyss, the former chief executive officer, chairman of the board and largest shareholder, was not charged in the case. Huggins reported to Wyss.

The four executives pleaded guilty to one misdemeanor count. By law, Judge Legrome D. Davis could not sentence the men to more than one year. Huggins went to prison for nine months, as did Higgins. Bohner received an eight month sentence and Walsh got five months.

Families of the three patients who died are suing the company and/or individuals involved.

On June 14, health-care giant Johnson & Johnson completed its $19.3 billion acquisition of Synthes.

A link to previous Inquirer stories on the Synthes bone cement case is here.



Staff Writer
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at or 215-854-4506.

David Sell Staff Writer
Also on
letter icon Newsletter